Dr Reddy’s Laboratories has purchased the oral penicillin laboratory of GlaxoSmithKline based in USA

In a major buyout at the global pharmaceutical scenario, Dr Reddy’s Laboratories has purchased the oral penicillin laboratory of GlaxoSmithKline based in USA.

The transaction amount is not yet disclosed by Dr Reddy’s, a pharma major.

“This acquisition allows us to enter the US penicillin-containing antibacterial market segment and serve the needs of our customers. This is in line with our strategy to significantly scale up our generics business in North America, while providing an opportunity to explore additional synergy with our other businesses,” said, Abhijit Mukherjee, President (Global Generics Business), Dr Reddy’s Laboratory.